Fritextsökning
Innehållstyper
-
From Image to Results
3D multiplexing spatial omics workflows in neuroscience.
-
Novo Nordisk rasar efter bakslag för fetmaläkemedel – aktien på lägsta nivån sedan 2021
Danska läkemedelsbolaget Novo Nordisk faller runt 15 procent till lägsta nivån sedan juni 2021 efter att fetmaläkemedlet Cagrisema missat målet om att vara mins...
-
How MoniDose strengthened their regulatory confidence—fast
When MoniDose began their startup journey, regulations were their biggest challenge. Missing early design inputs tied to standards could have meant costly redesigns later.
-
Painkiller cuts recurrence risk by more than 50% – national guidelines updated
Sweden’s national guidelines for colon and rectal cancer have been updated — just nine months after the previous revision. The move follows new Swedish research...
-
Sprint Bioscience builds the molecules that will become new medicines
In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinic...
-
Dying man saved by artificial lung system
An external artificial lung system kept a critically ill man alive for two days until he could undergo a lung transplant. In the longer term, researchers hope t...
-
Transport validation for medical devices
According to MDR 2017/745, “Devices shall be designed and manufactured in such a way as to ensure that their characteristics and performance during their intend...
-
FDA launches investigation into gene therapy following child death
The U.S. Food and Drug Administration (FDA) has initiated a safety investigation into Takeda’s Adzynma after reports that a child has died during treatment. The...
-
Svenska hushåll bland de mest intresserade av fetmaläkemedel
I vart sjunde svenskt hushåll finns någon som vill testa injicerbara fetmaläkemedel, och 7,5 procent har redan gjort det. Det enligt en ny europeisk undersöknin...
-
Xspray Pharma backade efter uppgifter om krav på ny studie
Forskningsbolaget Xspray Pharma föll med drygt 9 procent under torsdagen efter att ha varit ner som mest med cirka 19 procent. Orsaken var ett tidigare känt FDA...
-
De vanligaste frågorna om ånga
Våra ångexperter har gjort en lista över de vanligaste frågorna om ånga och ångsystem. Läs svaren här och spara tid genom att inte behöva söka efter svaren.
-
Lista: De får del av Cancerfondens miljardsatsning
Under 2025 genomför Cancerfonden sin största forskningssatsning hittills. Mer än en miljard kronor avsätts till projekt som ska förbättra den tidiga upptäckten av cancer.
-
FDA leaders seek to scrap two-study requirement
A single pivotal study may be sufficient to secure approval for a new medicine in the United States. That is the message delivered by FDA Commissioner Marty Mak...
-
Study: Autism as common in girls as in boys
Autism may be just as common in girls as in boys, but girls are diagnosed significantly later and less often during childhood, according to a large Swedish registry study.
-
”Trickier than bacteria”: Why severe fungal infections are on the rise
There’s a reason Earth is sometimes called the planet of fungi. These ancient organisms – billions of years old and more closely related to animals than to plan...
-
Anna Törner: ”Drug prices – an important driver of innovation”
We live under the illusion that no price is too high when it comes to health, but that simply isn’t true, writes Anna Törner.
-
Obesity dominates as future blockbusters are identified
Two drug candidates targeting obesity and diabetes stand out sharply in Clarivate’s newly selected “starting eleven” of potential future blockbusters worth watching.
-
De får medicinpriset för upptäckt av immuntolerans
Året Nobelpris i fysiologi eller medicin tilldelas Mary Brunkow, Fred Ramsdell och Shimon Sakaguchi.
-
Pharma Outsourcing – Find the Right Partner
-
Vaccine project targeting congenital infection scrapped in late-stage trial – “Clearly disappointed”
Hope for the first vaccine against the world’s most common congenital infection has taken a serious hit
-
Southern Swedish company Aqilion develops drug for eosinophilic esophagitis
When Aqilion began developing a drug for eosinophilic esophagitis, the molecule was classified as an orphan drug. But the prevalence of the disease now appears ...
-
Vad utmärker de tillverkare som lyckats med en snabb MDR-certifiering?
revisionsstart till utfärdat certifikat varierar mellan olika tillverkare. Utifrån de MDR-certifikat vi har utfärdat kan vi se att de fall som haft kortare cert...
-
ZEISS continues to drive digital era forward in ophthalmology
2 million digitally planned cataract cases in the U.S. alone.
-
“Ozempic babies” – myth or reality?
Have weight-loss drugs such as Ozempic led to a rise in unplanned pregnancies? Life Science Sweden takes a closer look.